PFBT
BEAT

Parkside Financial Bank & Trust’s BioTelemetry, Inc. BEAT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-107
Closed -$8K – 1747
2020
Q4 		$8K Buy
107
+75
+234% +$3.93K ﹤0.01% 964
2020
Q3 		$1K Buy
32
+14
+78% +$585 ﹤0.01% 1497
2020
Q2 		$1K Buy
18
+7
+64% +$314 ﹤0.01% 1447
2020
Q1 		$0 Sell
11
-221
-95% -$10.2K ﹤0.01% 1765
2019
Q4 		$11K Buy
232
+28
+14% +$1.21K ﹤0.01% 788
2019
Q3 		$8K Sell
204
-103
-34% -$4.45K ﹤0.01% 840
2019
Q2 		$15K Sell
307
-12
-4% -$631 ﹤0.01% 719
2019
Q1 		$20K Sell
319
-832
-72% -$57.1K 0.01% 617
2018
Q4 		$69K Buy
1,151
+1,128
+4,904% +$67.7K 0.02% 302
2018
Q3 		$1K Hold
23
– – ﹤0.01% 1502
2018
Q2 		$1K Hold
23
– – ﹤0.01% 1505
2018
Q1 		$1K Buy
23
+11
+92% +$362 ﹤0.01% 1419
2017
Q4 		$0 Sell
12
-5
-29% -$145 ﹤0.01% 1592
2017
Q3 		$1K Hold
17
– – ﹤0.01% 1343
2017
Q2 		$1K Hold
17
– – ﹤0.01% 1370
2017
Q1 		$0 Buy
+17
New +$421 ﹤0.01% 1642

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Parkside Financial Bank & Trust's BEAT Position: Q1 2021 in Review

Parkside Financial Bank & Trust sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 107 shares — an estimated $8K sold.

Parkside Financial Bank & Trust first reported a position in BEAT in Q1 2017 and held it in 16 quarters. The position peaked at $69K in Q4 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Parkside Financial Bank & Trust reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 107 BioTelemetry, Inc. shares in Q1 2021, an estimated $8K.
  • Parkside Financial Bank & Trust first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 16 quarters.
  • Parkside Financial Bank & Trust's BioTelemetry, Inc. position peaked at $69K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2021, filed 10 May 2021.